中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Synthesis of triazolotriazine derivatives as c-Met inhibitors

文献类型:期刊论文

作者Guo, Yuting1,2; Peng, Xia3; Ji, Yinchun3; Zhang, Yitong1,3; Ding, Jian1,3; Zhan, Zhengsheng2; Ai, Jing1,3; Duan, Wenhu1,2
刊名MOLECULAR DIVERSITY
出版日期2020-03-10
页码8
关键词Receptor tyrosine kinase c-Met Triazolotriazine SAR Cellular potency
ISSN号1381-1991
DOI10.1007/s11030-020-10067-5
通讯作者Zhan, Zhengsheng(zszhan@simm.ac.cn) ; Ai, Jing(jai@simm.ac.cn) ; Duan, Wenhu(whduan@simm.ac.cn)
英文摘要Receptor tyrosine kinase c-Met is an important antitumor drug target. Triazolotriazine analogues2-10were prepared efficiently and evaluated the enzymatic and cellular c-Met activities. Brief structure-activity relationships of triazolotriazine core and CF2-quinoline part were investigated, leading to the discovery of compound8with nanomolar enzymatic c-Met activity, and subnanomolar MKN45 and EBC-1 cellular potencies. The proposed binding model of 8 and c-Met unraveled that two canonical hydrogen bonds and a pi-pi stacking interaction formed between the inhibitor and the ATP binding site of c-Met kinase domain, which accounted for its potent c-Met activities. [GRAPHICS] .
WOS关键词GROWTH-FACTOR RECEPTOR ; KINASE INHIBITOR ; HIGHLY POTENT ; DISCOVERY ; IDENTIFICATION ; PROTOONCOGENE ; CABOZANTINIB ; METASTASIS ; VOLITINIB ; PATHWAY
资助项目Shanghai Sailing Program[17YF1423300] ; Youth Innovation Promotion Association of CAS[2018324] ; National Science and Technology Major Project Key New Drug Creation and Manufacturing Program, China[2018ZX09711002-011-016] ; Strategic Priority Research Program of the Chinese Academy of Sciences[XDA12020228] ; National Natural Science Foundation of China[21702220]
WOS研究方向Biochemistry & Molecular Biology ; Chemistry ; Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000562581300001
出版者SPRINGER
源URL[http://119.78.100.183/handle/2S10ELR8/292411]  
专题新药研究国家重点实验室
通讯作者Zhan, Zhengsheng; Ai, Jing; Duan, Wenhu
作者单位1.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Med Chem, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Guo, Yuting,Peng, Xia,Ji, Yinchun,et al. Synthesis of triazolotriazine derivatives as c-Met inhibitors[J]. MOLECULAR DIVERSITY,2020:8.
APA Guo, Yuting.,Peng, Xia.,Ji, Yinchun.,Zhang, Yitong.,Ding, Jian.,...&Duan, Wenhu.(2020).Synthesis of triazolotriazine derivatives as c-Met inhibitors.MOLECULAR DIVERSITY,8.
MLA Guo, Yuting,et al."Synthesis of triazolotriazine derivatives as c-Met inhibitors".MOLECULAR DIVERSITY (2020):8.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。